Table of contents

Original Articles

• Docetaxel in combination with carboplatin for chemo-naive patients with epithelial ovarian cancer (1 October, 2002)

  Y. Aoki, T. Sato, I. Tsuneki, M. Watanabe, H. Kase, K. Fujita, H. Kurata, K. Tanaka
• Thiotepa in combination with cisplatin for primary epithelial ovarian cancer: A phase II study (1 October, 2002)

  M. E. Gordinier, A. P. Kudelka, J. J. Kavanagh, J. T. Wharton, R. S. Freedman
• Comparison of serum vascular endothelial growth levels between patients with and without ovarian malignancies (1 October, 2002)

  K. Dehaven, D. D. Taylor, C. Gercel-Taylor
• P53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer

  (1 October, 2002)

  R. A. M. Sagarra, L. A. L. A. Andrade, E. Z. Martinez, G. A. Pinto, K. J. Syrjänen, S. F. M. Derchain
• Influences on the risk of recurrent high grade cervical abnormality (1 October, 2002)

  H. Mitchell, J. Hocking
• Age-restricted cervical screening: HPV testing at age 50 identifies a high risk group for cervical disease (1 October, 2002)

  M. E. Cruickshank, G. Chambers, G. Murray, L. Mckenzie, C. Donaldson, J. Andrew, M. K. Campbell, H. C. Kitchener
• Codon 72 polymorphism of p53 in Israeli Jewish cervical cancer patients and healthy women (1 October, 2002)

  S. Arbel-Alon, J. Menczer, N. Feldman, M. Glezerman, L. Yeremin, E. Friedman
• Mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) chemotherapy for gynecological sarcomas (1 October, 2002)

  M. L. Pearl, M. Inagami, D. L. Mccauley, F. A. Valea, E. Chalas, M. Fischer
• Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas (1 October, 2002)

  P. Pautier, C. Genestie, K. Fizazi, P. Morice, C. Mottet, C. Haie-Meder, A. Le Cesne, C. Lhommé
• Utility of lymphangiography in the prediction of lymph node metastases in patients with cervical cancer (1 October, 2002)

  A. R. Munkarah, A. Jhingran, R. B. Iyer, S. Wallace, P. J. Eifel, D. Gershenson, T. W. Burke